Amgen Inc (NAS:AMGN)
$ 305.84 -0.66 (-0.22%) Market Cap: 164.06 Bil Enterprise Value: 218.38 Bil PE Ratio: 43.69 PB Ratio: 32.64 GF Score: 91/100

Q3 2019 Amgen Inc Earnings Call Transcript

Oct 29, 2019 / 09:00PM GMT
Release Date Price: $208.99 (+1.94%)
Operator

(technical difficulty)

My name is Ian and I will be your conference facilitator today for Amgen's Third Quarter Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thank you, Ian. Good afternoon, everybody. Thanks for joining us today. So we have a lot of ground to cover so I'll keep my comments very brief.

I'd like to begin by acknowledging those who are new in their coverage of our company, with the most recent being Geoff Meacham, who's now with Bank of America Merrill Lynch. I also want to correct an oversight on my part from our Q2 call as I inadvertently forgot to acknowledge Evan Seigerman of Crédit Suisse, who initiated back in the second quarter. A warm welcome to both Evan and Geoff.

Okay. So on to our Q3 results. Continued execution on our strategy, launch progress and pipeline advancement are some key themes that come to mind as I think about our third

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot